Buddinge Dyreklinik ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 3.0% 3.1% 1.9%  
Credit score (0-100)  0 0 57 54 69  
Credit rating  N/A N/A BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 1.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 4,697 6,914 8,168  
EBITDA  0.0 0.0 863 796 1,770  
EBIT  0.0 0.0 671 469 1,347  
Pre-tax profit (PTP)  0.0 0.0 609.6 462.1 1,358.4  
Net earnings  0.0 0.0 470.1 355.1 1,059.5  
Pre-tax profit without non-rec. items  0.0 0.0 610 462 1,358  

 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 722 1,099 963  
Shareholders equity total  0.0 0.0 510 639 1,470  
Interest-bearing liabilities  0.0 0.0 929 0.0 6.0  
Balance sheet total (assets)  0.0 0.0 3,192 2,084 2,435  

Net Debt  0.0 0.0 -599 -127 -478  
 
See the entire balance sheet

Volume 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 4,697 6,914 8,168  
Gross profit growth  0.0% 0.0% 0.0% 47.2% 18.1%  
Employees  0 0 8 12 13  
Employee growth %  0.0% 0.0% 0.0% 50.0% 8.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 3,192 2,084 2,435  
Balance sheet change%  0.0% 0.0% 0.0% -34.7% 16.9%  
Added value  0.0 0.0 670.9 469.3 1,347.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 810 -20 -628  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 14.3% 6.8% 16.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 21.1% 17.8% 60.2%  
ROI %  0.0% 0.0% 46.3% 44.6% 126.8%  
ROE %  0.0% 0.0% 92.2% 61.8% 100.5%  

Solidity 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  0.0% 0.0% 16.0% 30.7% 60.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -69.4% -15.9% -27.0%  
Gearing %  0.0% 0.0% 182.1% 0.0% 0.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 13.4% 1.8% 54.4%  

Liquidity 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 0.0 0.6 0.1 0.7  
Current Ratio  0.0 0.0 0.7 0.3 1.1  
Cash and cash equivalent  0.0 0.0 1,528.0 127.0 484.2  

Capital use efficiency 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -693.0 -952.2 54.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 84 39 104  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 108 66 136  
EBIT / employee  0 0 84 39 104  
Net earnings / employee  0 0 59 30 81